Literature DB >> 10444169

Neurolymphomatosis in Waldenström's macroglobulinaemia.

S Abad1, A M Zagdanski, S Brechignac, B Thioliere, J C Brouet, X Mariette.   

Abstract

We report four patients with Waldenström's macroglobulinaemia with an unusual neurologic complication, neurolymphomatosis, characterized by meningeal and root nerve infiltration by lymphoplasmacytic cells. Patients presented with rapidly progressive leg proximal weakness. Examination of cerebrospinal fluid disclosed lymphoplasmacytic cells. Magnetic resonance imaging of the lumbar spine was suggestive of a tissular infiltration of leptomeninges and nerve roots. Chemotherapy and irradiation of involved tissues led to a remarkable and sustained neurological improvement.

Entities:  

Mesh:

Year:  1999        PMID: 10444169     DOI: 10.1046/j.1365-2141.1999.01482.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Cranial and peripheral neuropathy due to leptomeningeal infiltration in a patient with Waldenstrom's macroglobulinemia.

Authors:  R Sutter; C Arber; A Tichelli; A J Steck; A Czaplinski
Journal:  J Neurol       Date:  2007-08-03       Impact factor: 4.849

Review 2.  Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO).

Authors:  Laurence Simon; Aikaterini Fitsiori; Richard Lemal; Jehan Dupuis; Benjamin Carpentier; Laurys Boudin; Anne Corby; Thérèse Aurran-Schleinitz; Lauris Gastaud; Alexis Talbot; Stéphane Leprêtre; Béatrice Mahe; Camille Payet; Carole Soussain; Charlotte Bonnet; Laure Vincent; Séverine Lissandre; Raoul Herbrecht; Stéphane Kremer; Véronique Leblond; Luc-Matthieu Fornecker
Journal:  Haematologica       Date:  2015-09-18       Impact factor: 9.941

3.  Nervous system lymphoid infiltration in Waldenström's macroglobulinemia. A case report.

Authors:  S Massengo; L Riffaud; X Morandi; M Bernard; M Verin
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

4.  Myelopathy from Waldenström's macroglobulinemia: improvement after Rituximab therapy.

Authors:  Bernardo Liberato; Adrienne Riethmuller; Raymond L Comenzo; Eric Lis; Jeffrey J Raizer
Journal:  J Neurooncol       Date:  2003-06       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.